Benzinga | Nov 4, 2021 06:32AM EDT

SVB Leerink Maintains Market Perform on Tandem Diabetes Care, Raises Price Target to $140

SVB Leerink analyst Danielle Antalffy maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Market Perform and raises the price target from $135 to $140.